Drug Makers May Cut Price of HIV/AIDS Drugs in Caribbean
Drug makers Bristol-Myers Squibb Co., GlaxoSmithKline and Roche are considering lowering the price their HIV/AIDS-related drugs for people living in the Caribbean, the Associated Press reports. Under the proposed deal, the price of antiretroviral therapy would be cut from $12,000 per patient per year to as little as $1,100 per patient per year, although the price would vary by country. Robert Lefebvre, a senior director with Bristol-Myers, said that the pharmaceutical firms will work with the World Health Organization and Caribbean officials to raise funds for and cut taxes on the medicines. The deal was discussed by drug industry representatives and officials from Caribbean nations in February, May and June. Although a regional deal has not yet been finalized, Caribbean officials say they are hopeful that an agreement will be approved at the XIV International AIDS Conference, which will be held July 7-12 in Barcelona, Spain. Caribbean Community Assistant Secretary-General Eddie Greene said that he is hopeful that Merck & Co. will also agree to cut its antiretroviral drug prices in the region. The Caribbean has the second-highest HIV infection prevalence rate in the world after sub-Saharan Africa. An estimated 2% of Caribbean residents, excluding those in Cuba, are estimated to be HIV-positive (Saunders, Associated Press, 6/28).
Global AIDS SpotlightKaisernetwork.org will feature special coverage of the XIV International AIDS Conference, taking place in Barcelona, Spain, July 7-12, including daily updates; Webcasts of select sessions and press conferences; and interviews with newsmakers and perspectives from those who have been fighting or covering AIDS. To find out more about how you can make this information available to your colleagues and constituents through your Web sites, listservs and newsletters, please visit http://www.kaisernetwork.org/aids2002, email firstname.lastname@example.org, or call kaisernetwork at (202) 347-5270. Sign up to receive a daily email during the week of the conference at http://www.kaisernetwork.org/aids2002/email. To bring you the most comprehensive and timely (same day) coverage of the conference, the Daily HIV/AIDS Report will publish at noon ET, July 8-12. Coverage from the opening sessions on Sunday, July 7, will be included in the Daily HIV/AIDS Report on Monday, July 8. This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.